Wells Fargo Remains Bullish on Micron Technology (MU) With a $130 PT

Micron Technology, Inc. (NASDAQ:MU) is one of the . Analyst Aaron Rakers from Wells Fargo maintained a Buy rating on Micron Technology, Inc. (NASDAQ:MU) on June 11, keeping the price target at $130.00. The analyst based the rating on the company's market positioning and advancements, stating that its recent announcement of the start of sample shipments of 36GB HBM4 12-High to key customers reflects a continuous and focused execution of the technology roadmap.
A close-up view of a computer motherboard with integrated semiconductor chips.
The analyst reasoned that this new product leverages the company's advanced 1-beta DRAM process, providing notable performance enhancement and power efficiency improvements compared to the previous generations.
Micron Technology, Inc. (NASDAQ:MU) also has a strategic focus on customizing logic base die with HBM4E+ and expanding the HBM:DDR5 trade ratio, factors that the analyst considers strong indicators of growth in the high-bandwidth memory market.
The analyst further reasoned that Micron Technology, Inc. (NASDAQ:MU) underwent significant revenue growth in its HBM segment in fiscal Q2 2025, exceeding $1 billion and suggesting continued growth in the upcoming quarters.
Micron Technology, Inc. (NASDAQ:MU) provides innovative memory and storage solutions. Its operations are divided into the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU).
While we acknowledge the potential of MU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Upturn

21 minutes ago

• Business Upturn

INVESTOR DEADLINE: Rocket Pharmaceuticals, Inc. (RCKT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, June 20, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, inclusive (the 'Class Period'), have until August 11, 2025 to seek appointment as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. Captioned Ho v. Rocket Pharmaceuticals, Inc. , No. 25-cv-10049 (D.N.J.), the Rocket Pharmaceuticals class action lawsuit charges Rocket Pharmaceuticals as well as one of Rocket Pharmaceuticals' top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit alleges that defendants provided investors with material information concerning Rocket Pharmaceuticals' Phase 2 pivotal trial of RP-A501 for the treatment of Danon disease while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket Pharmaceuticals knew Serious Adverse Events, including death of participants enrolled in the study, were a risk. In particular, Rocket Pharmaceuticals amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders, according to the complaint. The Rocket Pharmaceuticals class action lawsuit further alleges that on May 27, 2025, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event, ultimately, death, while enrolled in the study following a substantive amendment to the protocol that Rocket Pharmaceuticals failed to disclose to investors at the time management made the revision. On this news, the price of Rocket Pharmaceuticals stock fell, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Rocket Pharmaceuticals securities during the Class Period to seek appointment as lead plaintiff in the Rocket Pharmaceuticals class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Rocket Pharmaceuticals class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Rocket Pharmaceuticals class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]

CNN

23 minutes ago

• CNN

Why aren't tariffs causing inflation?

Why aren't tariffs causing inflation? For the past year, many economists warned that tariffs would increase prices, but inflation is lower today than when President Trump took office. CNN's Matt Egan breaks down why this might be the case and how economists expect that to change in the coming months. 01:09 - Source: CNN Vertical Trending Now 15 videos Why aren't tariffs causing inflation? For the past year, many economists warned that tariffs would increase prices, but inflation is lower today than when President Trump took office. CNN's Matt Egan breaks down why this might be the case and how economists expect that to change in the coming months. 01:09 - Source: CNN 50 years of 'Jaws' and shark attacks As Steven Spielberg's summer blockbuster 'Jaws' turns 50, CNN's Harry Enten figures out how likely it is to be attacked by a shark and whether we should fear the waters. 01:57 - Source: CNN Erupting volcano puts Indonesians on high alert Mount Lewotobi Laki Laki, one of Indonesia's most active volcanoes, erupted Tuesday, sending an ash cloud high into the air. The country's volcanology agency has raised the alert level to the highest. 00:59 - Source: CNN The NHL Stanley Cup's perfect imperfections The Stanley Cup is one of the most iconic trophies in all of sports, but one of the reasons the NHL's championship trophy is so lionized is its perfect imperfections. CNN's Coy Wire spoke to The Keeper of the Cup Howie Borrow for a tour of some of the trophy's character-building bloopers. 01:02 - Source: CNN Storm chaser captures 'unprecedented' view of monster hailstones falling from sky Storm chaser and research scientist Sean Waugh has documented softball sized (or greater) hailstones in freefall with an ultra-high-tech camera mounted on a retrofitted research vehicle. The goal – to study and better understand what makes gigantic hail form, and how to better detect it and ultimately improve severe weather warnings. Sean speaks with CNN Meteorologist Derek Van Dam while on the road, capturing imagery of this very impactful and expensive natural phenomenon. (edited) 01:47 - Source: CNN Flash flood destroys apartment building An apartment building in West Virginia partially collapsed as flash floods hit the area. The governor's office said at least five people are dead and four people remain missing following the floods. 00:31 - Source: CNN After talking to hundreds of dads, this podcaster shares his two biggest lessons Dr. John Delony speaks to millions of listeners on his popular podcast about mental health, family and relationships. As a therapist, he's used to offering advice to struggling fathers, but we asked him about the biggest lessons he's learned as a dad. 01:32 - Source: CNN Rare deep-sea squid filmed alive for first time Scientists have captured the first-ever footage of the elusive Gonatus antarcticus squid alive in its deep-sea habitat. CNN's Jeremy Roth describes the rare encounter. For more on this story, visit 01:12 - Source: CNN Trump draws boos and cheers at Kennedy Center President Donald Trump drew charged reactions of both admiration and ire at the Kennedy Center's opening night of "Les Misérables." 00:29 - Source: CNN The many adventures of the Stanley Cup Winner's of the NHL's Stanley Cup each get to take the cup for a day and do whatever they want with it. CNN's Coy Wire recounts some of the Cup's wildest days out. 00:43 - Source: CNN BTS members discharged from South Korean military One of the world's biggest boybands could soon be making a comeback with six out of seven members of K-Pop supergroup BTS now discharged from South Korea's mandatory military service. The band plans to reunite at some point later this year. 00:47 - Source: CNN Combs requests mistrial for a second time CNN's Elizabeth Wagmeister explains that Sean "Diddy" Combs' defense team requested a mistrial for a second time, which was denied. Combs' team accused the prosecution of presenting false testimony from Bryana Bongolan, a friend of Cassie Ventura's, who testified that Combs dangled her over a balcony. 01:26 - Source: CNN Tennessee sheriff's office airlifts escaped zebra to safety DEK: A zebra, that escaped from its owner in Christiana, Tennessee was captured on Sunday and airlifted to safety by the local sheriff's office. The animal, named Ed, had been reported missing just a day after he was acquired by its owners in Rutherford County. They have since been reunited. 00:35 - Source: CNN Jamie Foxx breaks down during BET Awards acceptance speech Jamie Foxx was overcome with emotion while accepting the Ultimate Icon Award at the BET Awards. He reflected on his 2023 health scare. 00:45 - Source: CNN See what's coming to your iPhone and other Apple devices Apple announced major software updates at its annual Worldwide Developers Conference. Most of the new features won't reach users' devices for a few months when OS 26 releases this fall. 01:49 - Source: CNN

Bloomberg

23 minutes ago

• Bloomberg

Trump Says Iran Wants to Speak With US, Not Europe

Bloomberg Markets: The Close President Donald Trump says two weeks is the maximum amount of time he will allow to pursue diplomacy with Iran while speaking with reporters. (Source: Bloomberg)